INTROMEDIC CO., LTD. Financials IntroMedic Co., Ltd.
Equities
A150840
KR7150840007
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,850 KRW | -4.26% |
|
-.--% | -.--% |
| 2023 | IntroMedic Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2023 | NexOptic Technology Corp. Signs MOU with IntroMedic Co., Ltd | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 65,601 | 75,366 | 103,519 | 251,198 | 223,669 | 223,669 |
| Enterprise Value (EV) 1 | 73,299 | 78,739 | 101,125 | 254,962 | 226,093 | 229,760 |
| P/E ratio | -11.1 x | -3.41 x | -11.1 x | -16.9 x | -9.61 x | -32.9 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 6.64 x | 8.53 x | 17.4 x | 31.9 x | 22.6 x | 22 x |
| EV / Revenue | 7.42 x | 8.91 x | 17 x | 32.4 x | 22.9 x | 22.6 x |
| EV / EBITDA | -23.5 x | -14.9 x | -17.7 x | -46.5 x | -80.6 x | -50.6 x |
| EV / FCF | -15.1 x | -20.5 x | -14.7 x | -9.4 x | 12.5 x | -44.1 x |
| FCF Yield | -6.64% | -4.89% | -6.82% | -10.6% | 8.02% | -2.27% |
| Price to Book | 4.52 x | 5.01 x | 4.81 x | 4.86 x | 15.1 x | 28.8 x |
| Nbr of stocks (in thousands) | 18,072 | 23,479 | 31,369 | 38,234 | 38,234 | 38,234 |
| Reference price 2 | 3,630 | 3,210 | 3,300 | 6,570 | 5,850 | 5,850 |
| Announcement Date | 3/18/19 | 3/18/20 | 3/17/21 | 3/21/22 | 3/23/23 | 3/21/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 9,874 | 8,836 | 5,963 | 7,871 | 9,878 | 10,158 |
| EBITDA 1 | -3,123 | -5,299 | -5,725 | -5,484 | -2,805 | -4,536 |
| EBIT 1 | -3,754 | -6,203 | -6,463 | -6,539 | -3,560 | -5,053 |
| Operating Margin | -38.02% | -70.2% | -108.4% | -83.08% | -36.04% | -49.74% |
| Earnings before Tax (EBT) 1 | -5,066 | -19,319 | -8,349 | -13,854 | -23,315 | -6,857 |
| Net income 1 | -5,065 | -18,937 | -8,224 | -13,742 | -23,265 | -6,817 |
| Net margin | -51.3% | -214.32% | -137.92% | -174.6% | -235.52% | -67.11% |
| EPS 2 | -328.5 | -942.0 | -297.4 | -389.1 | -608.5 | -178.0 |
| Free Cash Flow 1 | -4,864 | -3,849 | -6,896 | -27,119 | 18,135 | -5,209 |
| FCF margin | -49.26% | -43.56% | -115.66% | -344.56% | 183.59% | -51.28% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/18/19 | 3/18/20 | 3/17/21 | 3/21/22 | 3/23/23 | 3/21/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 7,699 | 3,372 | - | 3,765 | 2,424 | 6,091 |
| Net Cash position 1 | - | - | 2,394 | - | - | - |
| Leverage (Debt/EBITDA) | -2.465 x | -0.6364 x | - | -0.6866 x | -0.8643 x | -1.343 x |
| Free Cash Flow 1 | -4,864 | -3,849 | -6,896 | -27,119 | 18,135 | -5,209 |
| ROE (net income / shareholders' equity) | -38.8% | -124% | -44.8% | -37.4% | -76.2% | -56.7% |
| ROA (Net income/ Total Assets) | -8.86% | -11.9% | -12.7% | -8.56% | -4.96% | -12.6% |
| Assets 1 | 57,148 | 158,753 | 64,700 | 160,601 | 469,229 | 54,170 |
| Book Value Per Share 2 | 803.0 | 641.0 | 686.0 | 1,351 | 388.0 | 203.0 |
| Cash Flow per Share 2 | 235.0 | 87.30 | 163.0 | 134.0 | 219.0 | 34.40 |
| Capex 1 | 462 | 1,738 | 58.7 | 381 | 615 | 912 |
| Capex / Sales | 4.68% | 19.67% | 0.98% | 4.85% | 6.23% | 8.98% |
| Announcement Date | 3/18/19 | 3/18/20 | 3/17/21 | 3/21/22 | 3/23/23 | 3/21/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 167M | |
| -3.25% | 15B | |
| -38.91% | 2.8B | |
| -12.68% | 2.45B | |
| -12.18% | 1.46B | |
| -.--% | 1.12B | |
| +45.05% | 529M | |
| +96.15% | 504M | |
| +14.23% | 245M | |
| -19.37% | 183M |
- Stock Market
- Equities
- A150840 Stock
- Financials IntroMedic Co., Ltd.
